JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611483200 on May 18, 2007

J. Biol. Chem., Vol. 282, Issue 29, 21370-21381, July 20, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/29/21370    most recent
M611483200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobles, K. N.
Right arrow Articles by Lefkowitz, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobles, K. N.
Right arrow Articles by Lefkowitz, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Active Conformation of beta-Arrestin1

DIRECT EVIDENCE FOR THE PHOSPHATE SENSOR IN THE N-DOMAIN AND CONFORMATIONAL DIFFERENCES IN THE ACTIVE STATES OF beta-ARRESTINS1 AND -2*

Kelly N. Nobles{ddagger}, Ziqiang Guan{ddagger}1, Kunhong Xiao§, Terrence G. Oas{ddagger}, and Robert J. Lefkowitz{ddagger}§2

From the Departments of {ddagger}Biochemistry and §Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710

beta-Arrestins are multifunctional adaptor proteins that regulate seven transmembrane-spanning receptor (7TMR) desensitization and internalization and also initiate alternative signaling pathways. Studies have shown that beta-arrestins undergo a conformational change upon interaction with agonist-occupied, phosphorylated 7TMRs. Although conformational changes have been reported for visual arrestin and beta-arrestin2, these studies are not representative of conformational changes in beta-arrestin1. Accordingly, in this study, we determine conformational changes in beta-arrestin1 using limited tryptic proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis in the presence of a phosphopeptide derived from the C terminus of the V2 vasopressin receptor (V2Rpp) or the corresponding unphosphorylated peptide (V2Rnp). V2Rpp binds specifically to beta-arrestin1 causing significant conformational changes, whereas V2Rnp does not alter the conformation of beta-arrestin1. Upon V2Rpp binding, we show that the previously shielded Arg393 becomes accessible, which indicates release of the C terminus. Moreover, we show that Arg285 becomes more accessible, and this residue is located in a region of beta-arrestin1 responsible for stabilization of its polar core. These two findings demonstrate "activation" of beta-arrestin1, and we also show a functional consequence of the release of the C terminus of beta-arrestin1 by enhanced clathrin binding. In addition, we show marked protection of the N-domain of beta-arrestin1 in the presence of V2Rpp, which is consistent with previous studies suggesting the N-domain is responsible for recognizing phosphates in 7TMRs. A striking difference in conformational changes is observed in beta-arrestin1 when compared with beta-arrestin2, namely the flexibility of the interdomain hinge region. This study represents the first direct evidence that the "receptor-bound" conformations of beta-arrestins1 and 2 are different.


Received for publication, December 14, 2006 , and in revised form, April 25, 2007.

* This work was supported in part by Grants HL16037 and HL70631 (to R. J. L.) from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by LIPID MAPS Large Scale Collaborative Grant GM069338 from the National Institutes of Health.

2 To whom correspondence should be addressed: Howard Hughes Medical Institute, Duke University Medical Center, Box 3821, Durham, NC 27710. Tel.: 919-684-2974; Fax: 919-684-8875; E-mail: lefko001{at}receptor-biol.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B. W. Jones and P. M. Hinkle
Arrestin Binds to Different Phosphorylated Regions of the Thyrotropin-Releasing Hormone Receptor with Distinct Functional Consequences
Mol. Pharmacol., July 1, 2008; 74(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Barki-Harrington and H. A. Rockman
{beta}-Arrestins: Multifunctional Cellular Mediators
Physiology, February 1, 2008; 23(1): 17 - 22.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.